Tweenvest Stocks

Evoke Pharma, Inc. (NasdaqCM: EVOK)

Health Care · Pharmaceuticals · US

$—

— today · — 1Y

Evoke Pharma, Inc. (NasdaqCM: EVOK) operates in the Pharmaceuticals industry within the Health Care sector.

trading between 4.41 and 11.00.

Tweenvest scores Evoke Pharma, Inc. across four factors: quality 37/100, value 60/100. Its strongest factor is value.

EVOK price history

Not enough price history to draw a chart yet.

Key figures

Market cap
—
Revenue (TTM)
$14.42M
P/E
—
EPS
-1.88
Dividend yield
—
Beta (5Y)
—
52-week high
$11.00
52-week low
$4.41
Avg volume (3M)
—
Shares outstanding
—
Employees
3
Next earnings
—

About Evoke Pharma, Inc.

Evoke Pharma, Inc. operates as a specialized pharmaceutical entity, primarily focused on inventing and bringing to market therapeutic agents for various digestive system illnesses. The company's lead development candidate is Gimoti, a metoclopramide nasal spray, which has progressed through and completed its Phase 3 clinical trials. This medicine is being developed to mitigate symptoms associated with both acute and recurring diabetic gastroparesis, specifically in female patients. Evoke Pharma distributes its offerings to a broad base of healthcare professionals, encompassing digestive disease specialists, internists, general practitioners, and certain other medical providers. Established in 2007, the company's corporate offices are situated in Solana Beach, California.

ISIN
US30049G3020
Founded
2007
Listed since
Sep 25, 2013
Exchange
Nasdaq Capital Market
Currency
USD
CompanyMarket capPriceDay
Regnum Corp.OTCPK: RGMP$23.00$——
CanaQuest Medical Corp.OTCPK: CANQ.F$21.00$——
The Greenrose Holding Company Inc.OTCPK: GNRS.Q$18.00$——
Lowell Farms Inc.OTCPK: LOWL.F$18.00$0.00—
West Island Brands Inc.OTCPK: WIBF.F$17.00$0.00—
9 Meters Biopharma, Inc.OTCPK: NMTR.Q$14.00$——
Biostar Pharmaceuticals, Inc.OTCPK: BSPM$3.00$0.00—
BC Craft Supply Co. Ltd.OTCPK: CRFT.F$2.00$——

Browse every Pharmaceuticals company →

Figures last refreshed Oct 11, 2026.